Business Update19 Sept 2025, 05:41 pm
Datavant and Indegene Partner to Power More Efficient Clinical Trial Recruitment
AI Summary
Datavant, the data collaboration platform trusted for healthcare, announced a strategic partnership with Indegene, a leading digital-first, life sciences commercialization company, to enhance patient recruitment for clinical trials. The partnership aims to match more eligible patients, including those with rare and complex diseases, to appropriate clinical trials by embedding Datavant’s bespoke data enrichment capabilities into Indegene’s NEXT Patient Recruitment platform. This collaboration streamlines the identification of suitable participants for studies based on specific health data criteria, reducing site-level screen failures and accelerating enrollment timelines.
Key Highlights
- Datavant and Indegene partner to enhance patient recruitment for clinical trials
- Collaboration focuses on rare disease and other complex studies
- Embedding Datavant’s data enrichment capabilities into Indegene’s NEXT Patient Recruitment platform
- Streamlines the identification of suitable participants for studies based on specific health data criteria
- Reduces site-level screen failures and accelerates enrollment timelines